Long-Acting Sandostatin as an Effective Therapy for Osler-Weber-Rendu Disease: A Case Report

Background: Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-WeberRendu disease, is a genetic disease that follows an autosomal dominant inheritance pattern. It is characterized by the presence of mucocutaneous telangiectasias, which are small dilated blood vessels found on the skin and mucous membranes. Individuals with HHT most commonly present with epistaxis and gastrointestinal bleeding, that can subsequently lead to the development of iron deficiency anemia. Case report: Here we describe the case of a 54-year-old female patient with a known history of diabetes mellitus and HHT. She developed severe iron deficiency anemia secondary to gastrointestinal bleeding, necessitating intravenous iron replacement and multiple blood transfusions.